Form 4: Surmodics CFO Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Surmodics' Chief Financial Officer, Timothy J. Arens, sold 1,786 shares of common stock to cover tax obligations.

Summary

  • Timothy J. Arens, the Chief Financial Officer of Surmodics Inc., sold 1,786 shares of the company's common stock on November 30, 2024.
  • The sale was executed at a price of $39.45 per share.
  • This transaction was done to cover tax obligations related to stock awards.
  • Following the transaction, Mr. Arens directly owns 68,564 shares of Surmodics common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction for executives to manage their tax liabilities related to stock-based compensation. It is common for executives to sell shares to cover these obligations.

Comparison to Industry Standards

  • Executive stock sales for tax purposes are a common practice across publicly traded companies.
  • The volume of shares sold is relatively small compared to the total shares held by the CFO, suggesting this is a routine transaction rather than a significant divestment.

Stakeholder Impact

  • The transaction is unlikely to have a significant impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

DateDescription
11/30/2024Date of the stock sale transaction.
12/03/2024Date the Form 4 was signed.

Keywords

Surmodics, SRDX, CFO, Timothy J. Arens, stock sale, insider trading, Form 4, tax obligations

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.